Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group
(Q44227096)
scientific article
scientific article
Language:
Current Data About
Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group
other details
description | scientific article |
External Links
(P356) |
10.1023/A:1020625423524
|
(P698) |
12448662
|
(P6179) |
1014598744
|